References
- Purty S, Saranathan R, Prashanth K. The expanding spectrum of human infections caused by Kocuria species: a case report and literature review. Emerg Microbes Infect. 2013;2(10):e71.
- Savini V, Catavitello C, Masciarelli G, et al. Drug sensitivity and clinical impact of members of the genus Kocuria. J Med Microbiol. 2010;59:1395–1402.
- Ben-Ami R, Navon-Venezia S, Schwartz D, et al. Erroneous reporting of coagulase-negative Staphylococci as Kocuria spp. by the Vitek 2 system. J Clin Microbiol. 2005;43(3):1448–1450.
- Dunn R, Bares S, David MZ. Central venous catheter-related bacteremia caused by Kocuria kristinae: case report and review of the literature. Ann Clin Microbiol Antimicrob. 2011;10:31.
- Meletis G, Gogou V, Palamouti M, et al. Catheter-related relapsing peritonitis due to Kocuria varians in a patient undergoing continuous ambulatory peritoneal dialysis. Nefrologia. 2012;32:541–542.
- Basaglia G, Carretto E, Barbarini D, et al. Catheter-related bacteremia due to Kocuria kristinae in a patient with ovarian cancer. J Clin Microbiol. 2002;40(1):311–313.
- Altuntas F, Yildiz O, Eser B, et al. Catheter-related bacteremia due to Kocuria rosea in a patient undergoing peripheral blood stem cell transplantation. BMC Infect Dis. 2004;4(1):62.
- Lai CC, Wang JY, Lin SH, et al. Catheter-related bacteraemia and infective endocarditis caused by Kocuria species. Clin Microbiol Infect. 2011;17(2):190–192.
- Doran MF, Crowson CS, Pond GR, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46(9):2287–2293.
- Koo S, Marty FM, Baden LR. Infectious complications associated with immunomodulating biologic agents. Infect Dis Clin North Am. 2010;24(2):285–306.
- UpToDate. [cited 2016 Jul 7]. Available from: http://www.uptodate.com/contents/tumor-necrosis-factor-alpha-inhibitors-bacterial-viral-and-fungal-infections
- Yun H, Xie F, Delzell E, et al. Risk of hospitalized infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy. Ann Rheum Dis. 2015;74(6):1065–1071.
- Curtis JR, Xie F, Chen L, et al. Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2012;64(10):1480–1489.